Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: JAMA Cardiol. 2016 Aug 1;1(5):519–528. doi: 10.1001/jamacardio.2016.0765

Table 2.

Crude incidence rates (per 1,000 person years) and adjusted* hazard ratios (95% confidence intervals) for incident coronary heart disease, heart failure hospitalization, or death; according to categories of 6-year change in high sensitivity cardiac troponin T (hs-cTNT), N=8838

Outcomes Absolute hs-cTNT change among all participants Relative change among persons
with measurable hs-cTNT values
Incident Detectable
(Baseline <5ng/L,
Follow-up ≥5ng/L)
Incident Elevated
(Baseline <14ng/L,
Follow-up ≥14ng/L)
>50%
Decrease
Change
≤50%
>50%
Increase
No
(N=3888)
Yes
(N=2152)
No
(N=8155)
Yes
(N=443)
(N=74) (N=2227) (N=1147)
Heart Failure n=235 n=260 n=761 n=134 n=10 n=309 n=234
  Incidence Rate 4.5 9.7 7.2 30.5 10.7 11.1 18.0
  Demographic
Model*
1 (ref) 2.05
(1.70–2.47)
1 (ref) 3.88
(3.20–4.71)
1.06
(0.57–2.00)
1 (ref) 1.64
(1.39–1.95)
  Full Model* 1 (ref) 1.96
(1.62–2.37)
1 (ref) 2.78
(2.27–3.40)
0.49
(0.23–1.01)
1 (ref) 1.60
(1.35–1.91)
Coronary Heart
Disease
n=330 n=301 n=969 n=119 n=9 n=374 n=239
  Incidence Rate 6.4 11.6 9.4 28.3 10.0 13.9 19.1
  Demographic
Model*
1 (ref) 1.36
(1.15–1.61)
1 (ref) 2.09
(1.72–2.55)
0.78
(0.40–1.52)
1 (ref) 1.31
(1.11–1.54)
  Full Model* 1 (ref) 1.38
(1.16–1.63)
1 (ref) 1.75
(1.43–2.15)
0.47
(0.22–1.03)
1 (ref) 1.28
(1.09–1.52)
Death n=508 n=486 n=1496 n=209 n=17 n=584 n=392
  Incidence Rate 9.5 17.5 13.7 42.8 17.7 20.1 28.2
  Demographic
Model*
1 (ref) 1.45
(1.27–1.66)
1 (ref) 2.41
(2.08–2.80)
1.00
(0.62–1.62)
1 (ref) 1.39
(1.22–1.58)
  Full Model* 1 (ref) 1.50
(1.31–1.72)
1 (ref) 2.10
(1.80–2.46)
0.57
(0.33–0.99)
1 (ref) 1.39
(1.22–1.59)
*

Demographic Model- Adjusted for age, sex, race-center; Full Model- Adjusted for age, sex, race-center, body mass index (kg/m3), C-reactive protein (mg/L), smoking (current; former; never), drinking (current; former; never), systolic blood pressure (mmHg), current use of blood pressure-lowering medication (yes or no), diagnosed diabetes (yes or no), LDL-cholesterol (mg/dL), HDL-cholesterol (mg/dL), triglycerides (mg/dL), and current use of cholesterol-lowering medication (yes or no), estimated GFR (mL/min/1.73m2), and left ventricular hypertrophy (yes or no, by Cornell criteria).

Absolute change categories are not mutually exclusive

Relative change sample (N=3448) only includes those who have measurable hs-cTnT values (≥3 ng/L) at both visits. Relative change is calculated as a percent of baseline hs-cTNT. The full model for this relative change exposure is further adjusted for visit 2 hs-cTNT.